Law360, New York (October 16, 2009, 2:42 PM ET) -- Sun India Pharmaceuticals Inc. has backed off from marketing generic tablets of the lucrative Alzheimer's drug Namenda, becoming the latest manufacturer to surrender to Forest Laboratories Inc. in an ongoing patent battle.
On Thursday U.S. District Judge Gregory M. Sleet of the U.S. District Court for the District of Delaware signed off on a stipulation and order that essentially resolves the action between Sun and Forest.
Forest and Merz Pharma GmbH & Co. KgaA first went on the litigation warpath in January 2008, trying to fend...
Sun Retreats From Alzheimer Drug Battle
To view the full article, take a free trial now.
